HOUSTON--(BUSINESS WIRE)-- Sixth paragraph, last sentence of the release should read: Second quarter revenue is expected to reflect approximately 3% year-on-year growth and sequential growth of 7%, with Adjusted EBITDA Margin in an expected range of 20% to 21%, or up 200 to 300 basis points year-on-year and sequentially in both cases based on the mid-point of second quarter guidance (instead of Second quarter revenue is expected to reflect approximately 20% year-on-year growth and sequential growth of 8%, with Adjusted EBITDA Margin in an expected range of 20% to 21%, or up 200 to 300 basis po...
LKQ Corporation Announces Results for First Quarter 2024 Revenue of $3.7 billion (an 11% increase compared to the same period in 2023)Diluted EPS2 of $0.59; adjusted diluted EPS1,2 of $0.82Operating cash flow of $253 million; free cash flow1 of $187 millionDividend of $0.30 per share approved to be paid in the second quarter of 2024Completed an offering of €750 million of unsecured 4.125% senior notesUni-Select synergies accelerated and increased from $55 million to $65 millionRepurchased $30 million of LKQ shares CHICAGO, April 23, 2024 (GLOBE NEWSWIRE) -- LKQ Corporation (Nasdaq: LKQ) ...
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, announced two oral presentations highlighting XEN1101 clinical data at the American Academy of Neurology (AAN) 2024 Annual Meeting in Denver, CO. Mr. Ian Mortimer, Xenon’s President and Chief Executive Officer, stated, “We are excited that our abstracts focused on XEN1101, including interim data from the ongoing X-TOLE open-label extension...
BROOKFIELD, Wis.--(BUSINESS WIRE)-- REV Group, Inc. (NYSE:REVG), a leading manufacturer of specialty vehicles, announces Amy Campbell has joined the company as Chief Financial Officer, effective today. Campbell sits on REV’s executive leadership team and reports to CEO and President Mark Skonieczny. This press release features multimedia. View the full release here: REV Group, Inc. (NYSE:REVG), a leading manufacturer of specialty vehicles, announces Amy Campbell has joined the company as Chief Financial Officer, effective today. Campbell sits on REV’s executive leadership team and reports to ...
HOUSTON--(BUSINESS WIRE)-- Expro Group Holdings N.V. (NYSE: XPRO) (“Expro” or the “Company”) will hold a conference call on April 25, 2024 to discuss results for the quarter ended March 31, 2024. The conference call is scheduled to begin at 9:00 a.m. Central Time (10:00 a.m. Eastern Time). A press release regarding the results will be issued before the market opens on April 25 and the press release, together with associated presentation slides, will be posted to the investor relations section of the Expro website in advance of the conference call. We encourage those who plan to dial-in to th...
OCALA, Fla.--(BUSINESS WIRE)-- REV Specialty Vehicles Segment, which includes fire apparatus brands E-ONE®, KME®, Ferrara™, Spartan Fire Chassis™, Spartan Emergency Response®, Smeal™, and Ladder Tower™, announces the Vector™, its all-electric North American-style fire truck, will feature on the April 15 episode of the award-winning series “.” REV Specialty Vehicles President Mike Virnig is the Vector spokesperson, interviewed by Jay Leno. This press release features multimedia. View the full release here: On April 15, Jay Leno's Garage will feature the all-electric North American-style Vector...
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the 2024 Bloom Burton & Co. Healthcare Investor Conference taking place April 16-17, 2024. Company Presentation Details:Date: Tuesday, April 16, 2024Time: 9:30 AM Eastern TimeWebcast: Presenters: Ian Mortimer, President and Chief Executive Officer A live webcast of the company presentation ...
HOUSTON--(BUSINESS WIRE)-- Expro (NYSE: XPRO), a leading provider of energy services, has published its latest sustainability report, highlighting the Company’s achievements in 2023 along with the progress it has made during that time working toward its near- and long-term environmental, social and governance (ESG) objectives. This press release features multimedia. View the full release here: Headshot of Mike Jardon, Chief Executive Officer of Expro. (Photo: Business Wire) Projects delivered this year, that are highlighted in the report, include a custom solution to support the testing of ne...
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the 23rd Annual Needham (Virtual) Healthcare Conference taking place April 8-11, 2024. Company Fireside Chat Presentation Details: Date:Thursday, April 11, 2024 Time:3:00 PM Eastern Time Webcast: Presenters:Ian Mortimer, President and Chief Executive Officer Sherry Aulin, Chief Financial Officer...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
LKQ Corporation to Release First Quarter 2024 Results on Tuesday, April 23, 2024 CHICAGO, March 19, 2024 (GLOBE NEWSWIRE) -- LKQ Corporation (Nasdaq: LKQ) will release its first quarter 2024 financial results on Tuesday, April 23, 2024. Conference Call Details LKQ will host a conference call and webcast on April 23, 2024 at 8:00 a.m. Eastern Time (7:00 a.m. Central Time) with members of senior management to discuss the Company's results. To access the investor conference call, please dial (833) 470-1428. International access to the call may be obtained by dialing (404) 975-4839. The inv...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.